Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > sirona is alive
View:
Comment by MirrorWorldMan on Nov 03, 2022 11:31am
Resilience? Don't see that here, maybe promise..
Comment by Pareto8020 on Nov 03, 2022 11:35am
Wonder how much they paid for that mention?  All their "news" mentions seem to be paid promo's vs genuine research or business articles. If they had released some of the Allergan deal details I'm certain there would have been wide spread coverage in addition to a lot more institutional interest and investment.  But hey - I'm sure Howard's master plan to keep ...more  
Comment by MirrorWorldMan on Nov 03, 2022 12:27pm
I remember all the paid promo mentions they have gotten over the years, nobody ever investigates if these commentators were correct in their predictions. It would be interesting to know their success rates if it is above zero
Comment by Pandora on Nov 04, 2022 6:05pm
From Dividend stocks.com : AbbVie Inc. (NYSE:ABBV) stock is down 3% in midday trading after the company posted a mixed earnings report. However, that’s a significant improvement from where AbbVie stock opened. In the pre-market, the stock dropped 6% after the released report.  This seems to be a case of ready, fire, aim. As investors have had a chance to look at the report ...more  
Comment by Pandora on Nov 08, 2022 4:22pm
Looks like less than 600 shares traded in total today?? Can we say Abbvie was a value add? :-))
Comment by bealert on Nov 08, 2022 5:00pm
Hi Pandora, and others All we can do now is hope Abbvie will produce down the road, maybe give us each enough to buy our coffins before we make our last Sirona trade. I'm thinkin we should have a little action before November is out, but I wouldn't count on too much yet at this point. Big deal today at the close:  bid 13, ask 13.5.  We haven't seem these numbers for a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities